Clinical Trial

ADHD, Gut Problems and Synbiotic

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The scope of this study is to evaluate the impact of a synbiotic product (a combination of probiotic bacteria and prebiotics) on symptoms reported by participants with ADHD. The main focus is to study the efficacy of the synbiotic product as compared to a placebo in improving emotion regulation and gut-health associated symptoms in adults with ADHD.
Trial Details
NCT Number NCT07717359
Lead Sponsor Super Synbiotics AB
Conditions ADHD, Gastrointestinal, Emotion Regulation Abilities
Enrollment 174 participants
Start Date 2026-09
Primary Completion 2027-10-31 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-21